L Origgi

897 total citations
23 papers, 511 citations indexed

About

L Origgi is a scholar working on Pathology and Forensic Medicine, Rheumatology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, L Origgi has authored 23 papers receiving a total of 511 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pathology and Forensic Medicine, 10 papers in Rheumatology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in L Origgi's work include Systemic Lupus Erythematosus Research (10 papers), Systemic Sclerosis and Related Diseases (9 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers). L Origgi is often cited by papers focused on Systemic Lupus Erythematosus Research (10 papers), Systemic Sclerosis and Related Diseases (9 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers). L Origgi collaborates with scholars based in Italy. L Origgi's co-authors include M. Vanoli, Monica Caronni, R Scorza, S Bazzi, Lorenzo Beretta, Maurizio Marchini, Guido Arpaia, B. Mascagni, Marco Sardina and R Scorza and has published in prestigious journals such as Annals of the New York Academy of Sciences, European Journal of Nuclear Medicine and Molecular Imaging and The American Journal of the Medical Sciences.

In The Last Decade

L Origgi

23 papers receiving 491 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L Origgi Italy 11 248 188 175 148 73 23 511
G. Mazzola Italy 14 127 0.5× 135 0.7× 77 0.4× 215 1.5× 59 0.8× 40 607
Lena Björnådal Sweden 8 254 1.0× 66 0.4× 435 2.5× 217 1.5× 55 0.8× 8 601
Z. Amoura France 9 70 0.3× 136 0.7× 274 1.6× 94 0.6× 76 1.0× 22 480
M Nakano Japan 14 70 0.3× 129 0.7× 255 1.5× 135 0.9× 105 1.4× 49 649
Takeshi Tojo Japan 13 482 1.9× 117 0.6× 285 1.6× 219 1.5× 252 3.5× 21 839
Luís Sáez-Comet Spain 9 78 0.3× 84 0.4× 275 1.6× 86 0.6× 113 1.5× 32 502
Ashley Pinckney United States 11 286 1.2× 240 1.3× 58 0.3× 114 0.8× 105 1.4× 17 564
James D. Northway United States 11 153 0.6× 107 0.6× 121 0.7× 174 1.2× 83 1.1× 19 597
Athiveeraramapandian Prabu United Kingdom 7 127 0.5× 74 0.4× 372 2.1× 206 1.4× 18 0.2× 14 470
Yuichiro Shirai Japan 11 176 0.7× 229 1.2× 106 0.6× 60 0.4× 98 1.3× 28 418

Countries citing papers authored by L Origgi

Since Specialization
Citations

This map shows the geographic impact of L Origgi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L Origgi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L Origgi more than expected).

Fields of papers citing papers by L Origgi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L Origgi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L Origgi. The network helps show where L Origgi may publish in the future.

Co-authorship network of co-authors of L Origgi

This figure shows the co-authorship network connecting the top 25 collaborators of L Origgi. A scholar is included among the top collaborators of L Origgi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L Origgi. L Origgi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Beretta, Lorenzo, et al.. (2006). Oral cyclophosphamide improves pulmonary function in scleroderma patients with fibrosing alveolitis: experience in one centre. Clinical Rheumatology. 26(2). 168–172. 33 indexed citations
2.
Beretta, Lorenzo, Monica Caronni, L Origgi, et al.. (2006). Hormone replacement therapy may prevent the development of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement. Scandinavian Journal of Rheumatology. 35(6). 468–471. 48 indexed citations
3.
Cappellari, A., L Origgi, Konstantina G. Yiannopoulou, et al.. (2006). Central nervous system involvement in HCV-related mixed cryoglobulinemia.. PubMed. 46(3). 149–58. 8 indexed citations
4.
Marchini, Maurizio, Ana Lleò, Monica Caronni, et al.. (2003). Hla class II antigens assoiated with lupus nephritis in italian SLE patients. Human Immunology. 64(4). 462–468. 44 indexed citations
5.
Caronni, Monica, S Bazzi, F Nador, et al.. (2002). Post‐Menopause is the Main Risk Factor for Developing Isolated Pulmonary Hypertension in Systemic Sclerosis. Annals of the New York Academy of Sciences. 966(1). 238–246. 73 indexed citations
6.
Castellani, Massimo, M. Vanoli, Giulia Bacchiani, et al.. (2001). Ventilation-perfusion lung scan for the detection of pulmonary involvement in Takayasu's arteritis. European Journal of Nuclear Medicine and Molecular Imaging. 28(12). 1801–1805. 17 indexed citations
7.
Vanoli, M., et al.. (1999). Non-invasive assessment of pulmonary artery involvement in Takayasu's arteritis.. PubMed. 17(2). 215–8. 13 indexed citations
8.
Origgi, L, et al.. (1998). Hepatitis C virus genotypes and clinical features in hepatitis C virus-related mixed cryoglobulinemia. International Journal of Clinical & Laboratory Research. 28(2). 96–99. 11 indexed citations
9.
Origgi, L, et al.. (1998). Central Nervous System Involvement in Patients With HCV-Related Cryoglobulinemia. The American Journal of the Medical Sciences. 315(3). 208–210. 47 indexed citations
10.
Origgi, L, et al.. (1998). Central Nervous System Involvement in Patients With HCV-Related Cryoglobulinemia. The American Journal of the Medical Sciences. 315(3). 208–210. 7 indexed citations
11.
Origgi, L, et al.. (1996). Successful Treatment With Cimetidine and Zinc Sulphate in Chronic Mucocutaneous Candidiasis. The American Journal of the Medical Sciences. 311(4). 189–190. 2 indexed citations
12.
Origgi, L, et al.. (1996). Successful Treatment With Cimetidine and Zinc Sulphate in Chronic Mucocutaneous Candidiasis. The American Journal of the Medical Sciences. 311(4). 189–190. 3 indexed citations
13.
Grigolo, Brunella, Ilaria Mazzetti, Rosa Maria Borzı̀, et al.. (1995). Comparison of different methods for the detection of autoantibodies in autoimmune diseases. International Journal of Clinical & Laboratory Research. 25(4). 205–210. 4 indexed citations
15.
Asero, Riccardo, et al.. (1988). Clinical findings in patients with SLE whose sera contain antibodies to ribosomal ribonucleoprotein. Immunology Letters. 18(1). 1–3. 5 indexed citations
16.
Asero, Riccardo, et al.. (1988). Detection of two associated precipitating autoantibodies (DA1 and DA2) in sera from patients with systemic lupus erythematosus.. PubMed. 26(2). 63–6. 2 indexed citations
17.
Origgi, L, et al.. (1988). Antibodies to Epstein-Barr virus and cytomegalovirus in primary Sjogren's syndrome.. PubMed. 67(4). 265–74. 6 indexed citations
18.
Origgi, L, Roberta Perego, Chen Hu, et al.. (1988). Anti-Epstein-Barr virus antibodies in systemic lupus erythematosus.. PubMed. 67(2). 116–22. 8 indexed citations
19.
Riboldi, Piersandro, et al.. (1987). The SL/Ki system in connective tissue diseases: incidence and clinical associations.. PubMed. 5(1). 29–33. 8 indexed citations
20.
Riboldi, Piersandro, et al.. (1985). Antinuclear antibodies in progressive systemic sclerosis.. PubMed. 3(3). 205–11. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026